Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1991
Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter studyS Andersch, N K Rosenberg, H Kullingsjö, et al.
Plos One|October 3, 2012
Association between change in normal appearing white matter metabolites and intrathecal inflammation in natalizumab-treated multiple sclerosisJohan Mellergård, Anders Tisell, Olof Dahlqvist Leinhard, et al.
Multiple Sclerosis and Related Disorders|October 15, 2022
Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosisH Tedeholm, F Piehl, J Lycke, et al.
NPJ Digital Medicine|May 11, 2022
Effect of self-managed lifestyle treatment on glycemic control in patients with type 2 diabetesChinmay Dwibedi, Emelia Mellergård, Amaru Cuba Gyllensten, et al.
Annals of Clinical and Translational Neurology|April 13, 2026
Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing-Remitting MSF Shawket, J Lycke, J Salzer, et al.
Nature Communications|October 31, 2023
Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosisJulia Åkesson, Sara Hojjati, Sandra Hellberg, et al.
Journal of Neuroinflammation|April 27, 2023
Prominent epigenetic and transcriptomic changes in CD4<sup>+</sup> and CD8<sup>+</sup> T cells during and after pregnancy in women with multiple sclerosis and controlsAlberto Zenere, Sandra Hellberg, Georgia Papapavlou Lingehed, et al.
Frontiers in Immunology|August 15, 2022
Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancyGeorgia Papapavlou Lingehed, Sandra Hellberg, Jesse Huang, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 9, 2023
Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapyElisa Longinetti, Simon Englund, Joachim Burman, et al.
Multiple Sclerosis and Related Disorders|January 5, 2023
Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohortSimon Englund, Marie Kierkegaard, Joachim Burman, et al.
Pageof 8